6505--Main-Blanket Purchase Agreement (BPA) Radiopharmaceuticals Supplies
Contact and place of performance
Anthony Marion
Not specified
Post Award -Amendment - Radiopharmaceuticals Supplies- 36C25623Q0158 Correct Performance Periods for Base and Options Performance periods and Delivery schedules is now changed from: Contract Period: Base POP Begin: 01-01-2023 POP End: 12-31-2023 Contract Period: Option 1 POP Begin: 01-01-2024 POP End: 12-31-2024 Contract Period: Option 2 POP Begin: 01-01-2025 POP End: 12-31-2025 Contract Period: Option 3 POP Begin: 0...
View moreThe Department of Veterans Affairs issued solicitation 36C25623Q0158 as a combined synopsis/solicitation for the procurement of radiopharmaceutical supplies. This requirement is classified under NAICS 325412, Pharmaceutical Preparation Manufacturing, and PSC 6505, Drugs and Biologicals. The primary purpose of this post-award amendment is to correct the performance periods and delivery schedules for the base year and four subsequent option years. Anthony Marion serves as the primary point of contact for this notice.
The revised schedule establishes a base performance period beginning April 1, 2023, and ending March 31, 2024. Option Year 1 runs from April 1, 2024, to March 31, 2025; Option Year 2 runs from April 1, 2025, to March 31, 2026; Option Year 3 runs from April 1, 2026, to March 31, 2027; and Option Year 4 runs from April 1, 2027, to March 31, 2028. These updates replace the previously stated calendar-year performance cycles.
Responses for this opportunity were due by December 9, 2022, following the initial publication on November 22, 2022. The notice includes four attachments: two versions of the solicitation document, a questions and responses PDF, and a combined synopsis PDF. The final update to this notice was recorded on December 23, 2022.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.